The Siemens CEO said he's focusing on AI investments for the industrial world, and expects revenue growth between 6 and 8% for the upcoming fiscal year, despite the challenging environment. This comes as Siemens decided to hand over a 30% stake in its MRI scanners division Healthineers to its own shareholders, to focus on software and related technology. Roland Busch spoke in an earnings interview with Anna Edwards from Munich. ...

Core Insights - Two healthcare diagnostics stocks are experiencing significant increases in their Benzinga Edge Rankings Growth scores, indicating renewed strength in their performance over the past week [1][2]. Group 1: Growth Scores Overview - The Growth score in Benzinga's Edge Rankings is determined by the rate at which a company increases its revenue and earnings, balancing long-term trends with recent performance [2]. - A notable spike in growth scores typically signifies a strong quarterly performance, enhancing the company's compounded annual growth rate and improving its ranking among peers [3]. Group 2: Company-Specific Insights - **Fonar Inc.**: The New York-based company, which designs and manufactures MRI scanners, saw its Growth score rise from 34.49 to 92.42 within a week. This increase occurred despite modest top-line growth in 2025 and a lack of major news catalysts, attributed instead to a growing network and record scan volumes recently [4][5]. - **Sonic Healthcare Ltd.**: This Australia-headquartered firm, providing laboratory and primary care services, experienced a jump in its Growth score from 28.09 to 73.21 over the past week. This surge is driven by accelerating earnings and expansion into multiple markets, with analysts noting the expected earnings accretion from recent acquisitions through fiscal 2027 [6].